ArticleFrontiers in oncology2025

Machine learning-based nomogram predicts heart failure risk in elderly relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy.

Dan Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.